Haibu Diabetes Digital Platform Trial Opens at BC Children's Hospital: Can Intelligent Care Technology Improve HbA1c in Paediatric Type 1 Diabetes?
247 Health News Editorial
·21 July 2026
·4 min read
·clinical-trialsThe ICP Trial at BC Children's Hospital is evaluating Haibu Diabetes — a digital platform integrating CGM and insulin delivery data — to determine whether intelligent care technology can improve HbA1c in children and adolescents with type 1 diabetes. Using a hybrid implementation-effectiveness design, the University of British Columbia-sponsored study will also assess real-world adoption and workflow integration across a multidisciplinary paediatric endocrinology team. Results are anticipated by 2028.
Originally reported by ClinicalTrials.gov
References
- 1.University of British Columbia. (2025). The Intelligent Care Platform (ICP) Trial of Haibu Diabetes - A quasi experimental Type 2 hybrid implementation-effectiveness study (NCT07712809). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07712809
- 2.Maahs, D. M., Hermann, J. M., DuBose, S. N., Miller, K. M., Heidtmann, B., DiMeglio, L. A., Clements, M., Moller, J. H., Skrivarhaug, T., Wolpert, H., & Beck, R. W. (2014). Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia, 57(8), 1578–1585. https://doi.org/10.1007/s00125-014-3207-5
- 3.Commissariat, P. V., Harrington, K. R., Whitehouse, A. L., Miller, K. M., Hilliard, M. E., Van Name, M., Anderson, B. J., & Laffel, L. M. (2020). I'm basically his pancreas: Parental burden and treatment responsibility in emerging adults with type 1 diabetes who still live with their parents. Diabetic Medicine, 37(7), 1213–1219. https://doi.org/10.1111/dme.14042
- 4.Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M., & Stetler, C. (2012). Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Medical Care, 50(3), 217–226. https://doi.org/10.1097/MLR.0b013e3182408812
- 5.Prahalad, P., Tanenbaum, M., Hood, K., & Maahs, D. M. (2018). Diabetes technology: Improving care, improving patient-reported outcomes and preventing complications in young people with type 1 diabetes. Diabetic Medicine, 35(4), 419–429. https://doi.org/10.1111/dme.13588
- 6.Lum, J. W., Majidi, S., Clements, M. A., Sherr, J. L., Messer, L. H., Wadwa, R. P., Buckingham, B. A., Forlenza, G. P., & Prahalad, P. (2022). Real-world continuous glucose monitoring in youth with type 1 diabetes: Patterns of use and glycemic outcomes. Diabetes Technology & Therapeutics, 24(6), 396–403. https://doi.org/10.1089/dia.2021.0349
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service